Date : 01 June 2026

| Companies | Headquarters | UK AI in Life Science Solutions |
| Isomorphic Labs | London, UK | AlphaFold 3 Architecture/Next-Gen Drug Design Engine |
| Lifebit | London, UK | Federated AI Platform and Lifebit CloudOS |
| Exscientia | Oxford, UK | Patient-First AI Platform and Centaur Biologist |
| Latent Labs | London, UK | Simon |
| BenevolentAI | London, UK | Benevolent Platform |
| Owkin | London, UK | MOSAIC/Federated Learning Network |
| Healx | Cambridge, UK | HealNet |
| Optibrium | Cambridge, UK | Cerella/StarDrop |
| Causaly | London, UK | Causaly Cloud Enterprise Platform |
| CHARM Therapeutics | London, UK | DragonFold |
The UK AI in life science market size was estimated at USD 210 million in 2025 and is predicted to increase from USD 249.9 million in 2026 to approximately USD 1195.88 million by 2035, expanding at a CAGR of 19% from 2026 to 2035.

Speak with a healthcare analyst about your research, consulting, or platform needs.